DVC
XLRN

Deer VII & Co’s Acceleron Pharma XLRN Stock Holding History

Deer VII & Co’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-175,075
Closed -$5.29M – 8
2014
Q3 		$5.29M Hold
175,075
– – 2.36% 5
2014
Q2 		$5.95M Sell
175,075
-930,889
-84% -$31.1M 1.68% 6
2014
Q1 		$38.2M Hold
1,105,964
– – 9.95% 3
2013
Q4 		$39.4M Buy
+1,105,964
New +$26.7M 9.51% 3

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deer VII & Co's XLRN Position: Q4 2014 in Review

Deer VII & Co sold out of Acceleron Pharma (XLRN) in Q4 2014, closing a stake of 175,075 shares — an estimated $5.29M sold.

Deer VII & Co first reported a position in XLRN in Q4 2013 and held it in 4 quarters. The position peaked at $39.4M in Q4 2013. 110 funds tracked by Wall St. Rank hold XLRN as of Q4 2014.

  • Deer VII & Co reported no remaining Acceleron Pharma position as of Q4 2014 after selling out during the quarter.
  • Deer VII & Co sold 175,075 Acceleron Pharma shares in Q4 2014, an estimated $5.29M.
  • Deer VII & Co first reported a position in Acceleron Pharma in Q4 2013 and held it in 4 quarters.
  • Deer VII & Co's Acceleron Pharma position peaked at $39.4M in Q4 2013.
  • 110 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2014.

Based on Deer VII & Co's 13F filing for Q4 2014, filed 17 Feb 2015.